How much upside is really left in Franklin FRAF Bearish Sentiment 20260506 DLPN Dolphin Ent Q3 2025 EPS beats estimates by 51 percent shares edge higher in daily trading The valuation impact of Vivos Therapeutics VVOS earnings quality VVOS Vivos Therapeutics Q4 Earnings Miss Wider Loss IVDA Iveda Solutions beats Q2 2024 EPS expectations by 412 percent but stock slips 067 percent in todays trading